Latest news
Statement from Novo Nordisk on Rebinyn and COVID-19 — The Coalition for Hemophilia B
Novo Nordisk receives US FDA approval for Xultophy 100/3.6 | World Pharma Today
KU Leuven spin-out enters licence agreement with Novo Nordisk | Science|Business
Press release - Novo Nordisk
Novo Nordisk U.S. News & Media Hub | Novo Nordisk U.S.
Press release - Novo Nordisk
Diabetes Treatment Market are Booming So Rapidly? Novo Nordisk,
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders | Business Wire
Novo Nordisk U.S. News & Media Hub | Novo Nordisk U.S.
Novo Nordisk launches once-a-week diabetes drug
CVS Health, Novo Nordisk Inc. join forces to provide enhanced, personalized support for obesity in retail settings | CVS Health
Untitled
Novo Nordisk's Wegovy supply woes were an unexpected boon for Saxenda
Press Releases - GEN - Genetic Engineering and Biotechnology News
Novo Nordisk Pharmatech A/S Press Releases - World Pharmaceutical Frontiers
Novo Nordisk Pauses Clinical Trials Investigating Concizumab - Hemophilia Federation of America
Driving change to defeat diabetes and other serious chronic diseases
Novo Nordisk (@novonordisk) / Twitter
Press release - Novo Nordisk
Novo Nordisk 2018Q4 - MidgardFinance.com
BIOCORP and NOVO NORDISK sign global partnership within diabetes on digital health
Maersk enters partnership with Novo Nordisk on global cold chain logistics
Press Release - Provision of HLA-homozygous iPS cellｓ to Novo Nordisk
